Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
Pharma News, 2025
Alvotech and Advanz
Alvotech and Advanz announce EC approval for Gobivaz biosimilar
Blood-Based Screening Test
Blood-Based Screening Test May Increase Preclinical Lung Cancer Detection
CorriXR Therapeutics
CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors
Medicxi unveils €500m fund for asset-centric biotechs
London-headquartered investment firm Medicxi has unveiled a €500m ($580m) fund to back innovative biotechs
FDA confirms Animal Rule
FDA confirms Animal Rule and PRV potential for Galidesivir in Marburg
AI-Driven Method
AI-Driven Method IDs Alzheimer Disease and Related Dementias in Primary Care
Health Check: Genetic Signatures holds course
Genetic chair Caroline Waldron says a board and operational overhaul should boost performance – and the share price.
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming patent expiry.
Alembic Pharma gets US FDA
Alembic Pharma gets US FDA approval for angina treatment drug Diltiazem
Scientists uncover new drug target
Scientists uncover new drug target in fight against antimicrobial resistance
General Proximity and Daiichi Sankyo link on oncology
General Proximity has entered a multi-target partnership with Daiichi Sankyo to apply the OmniTAC discovery platform to oncology programmes.
Amneal Secures FDA
Amneal Secures FDA Approval For First Generic Version Of Omnipaque Injection
1
2
3
4
5
6
7
8
9
